Robyn Elliott

Title: Robyn Elliott: Innovator in Pharmaceutical Formulations

Introduction

Robyn Elliott is a distinguished inventor based in Langwarrin, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of injectable compositions for cancer treatment. With a total of six patents to her name, her work is recognized for its innovative approach to drug delivery.

Latest Patents

Robyn's latest patents focus on a pharmaceutical formulation of paclitaxel combined with polyethoxylated castor oil. This formulation is designed to be relatively acidified to a pH of less than 8.1, preferably within a pH range of 5 to 7. Ethanol is optionally included in the formulation, which is specifically adapted for use in the body for cancer treatment. The formulation method involves mixing an acid with a carrier material, such as polyethoxylated castor oil, to create a carrier solution. After this, paclitaxel is added in a manner that ensures the resulting pH remains below 8.1. Ethanol may also be slurried with the paclitaxel before it is mixed with the carrier solution. Various acidifying agents are described, with anhydrous citric acid being a preferred choice.

Career Highlights

Robyn Elliott has established herself as a key figure in the pharmaceutical industry through her innovative work at Napro Biotherapeutics, Inc. Her expertise in drug formulation has led to advancements that enhance the efficacy of cancer treatments.

Collaborations

Robyn collaborates with notable colleagues, including David Reginald Carver and Timothy R. Prout. Their combined efforts contribute to the ongoing development of effective pharmaceutical solutions.

Conclusion

Robyn Elliott's contributions to pharmaceutical formulations exemplify her commitment to innovation in cancer treatment. Her work continues to impact the field positively, showcasing the importance of research and development in healthcare.